Brazil achieves milestone in eliminating lymphatic filariasis

The World Health Organization (WHO) congratulates Brazil for having eliminated lymphatic filariasis as a public health problem.

Opinion | One Year After Dobbs: Where Do We Go From Here?

Grossman is an ob/gyn. Here we are, just after the 1-year anniversary of the U.S. Supreme Court’s Dobbs decision. A patchwork of abortion policies have

June 27, 2023

The Future Of AI In Healthcare Is Not A Zero-Sum Game

Michael Drescher, VP of Payer Strategy at Xsolis The exasperation among doctors frustrated by prior authorization battles with health insurance providers is not unique. Prior authorization

October 18, 2024

Immunome buys desmoid tumor asset; UK looks into Thermo Fisher-Olink deal; Kyverna’s upsized IPO

Plus, news about Attralus, Sangamo, Mithra, NeOnc, 4D Molecular Therapeutics and Immix Biopharma: Immunome buys Ayala’s desmoid tumor asset: The biotech will pay $20 million

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.